Your browser doesn't support javascript.
loading
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.
Ganesan, Anuradha; Crum-Cianflone, Nancy; Higgins, Jeanette; Qin, Jing; Rehm, Catherine; Metcalf, Julia; Brandt, Carolyn; Vita, Jean; Decker, Catherine F; Sklar, Peter; Bavaro, Mary; Tasker, Sybil; Follmann, Dean; Maldarelli, Frank.
  • Ganesan A; Division of Infectious Diseases, National Naval Medical Center, Uniformed Services University, Bethesda, Maryland, USA. anuradha.ganesan@med.navy.mil
J Infect Dis ; 203(6): 756-64, 2011 Mar 15.
Article en En | MEDLINE | ID: mdl-21325137

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirroles / ARN Viral / Infecciones por VIH / VIH-1 / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Ácidos Heptanoicos Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Año: 2011 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirroles / ARN Viral / Infecciones por VIH / VIH-1 / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Ácidos Heptanoicos Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Año: 2011 Tipo del documento: Article